All Type of News
28 generics of Cialis have burst out for a month on March
Generic approvals for the impotency drug, ‘Cialis’, have burst out for a month on the last March.
According to the Ministry of Food and Drug Safety’s current state of pharmaceutical products on March, ‘tadalafil’ dru...
KRPIA is seeking for coexistence and cooperation with domestic pharmaceutical companies
The association of multinational pharmaceutical companies having business activities in Korea, the KRPIA (Korea Research-based Pharma Industry Association), is actively seeking cooperative measures with the domestic p...
Annual sale performance were KRW 350 million per an employee in listed pharmaceutical companies
It is known that annual sale performance was KRW 350 million per an employee in listed pharmaceutical companies last year.
There were also 3 companies with more than KRW 600 million sale performance per a person: Hwa...
Annual wages of employees in listed pharmaceutical companies exceeded KRW 50 million per a person
It is observed that employees working in listed pharmaceutical companies received more than KRW 50 million in average.
According to the YakupDotCom’s analysis result of 2015 business reports turned in by listed pharm...
The medical industry boiling up by KRW 12,000 influenza vaccination insurance fees for elders
While influenza vaccination insurance fees for elders, KRW 12,000 that are KRW 6,000 cheaper than infant ones, have generated controversy in local clinics, the leadership in the medical industry is having trouble in f...
Elderly medical expenses account for 35% in total as the number of seniors over 75 increases
It is known that medical expenses for elders accounted for 35% of the total last year. That is, it can be explained that the number of elders over 75 has increased due to acceleration of the aging and they tend to use...
Dong-A Pharmaceutical’s Bacchus challenges KRW 200 billion for the first time as a pharmaceutical company in KoreaPrice of the typical health drinks in Korea, Dong-A Pharmaceutical’s ‘Bacchus’ and Il-Yang Pharm’s ‘Wonbi-D’, will be raised in 1 April (today).
As an initial matter, wholesale...
|
Two different extreme ways in R&D of listed pharmaceutical companies, more than 20% of Hanmi against 0.1% of Daihan Pharm
While some pharmaceutical companies have invested more than 20% of sales in R&D (research and development), there are also pharmaceutical companies spending so less in R&D that the expenses cannot even be called as R&...
The more partnerships domestic pharmaceutical companies make with multinational companies, the stricter CP policies gets
Is it really inevitable for top domestic pharmaceutical companies promoting introduced products of multinational pharmaceutical companies to have tight CP (Compliance Program) policies?
It is criticized in the pharma...
The salary king as a directive in the pharmaceutical industry is CEO Jung-seok Kang of Dong-A Socio Holdings
CEO Jung-seok Kang of Dong-A Socio Holdings became the salary king among other executives in listed pharmaceutical companies.
According to the Financial Supervisory Service on the last 31st, CEO Jung-seok Kang of Don...
